Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, today announced new data to be presented at the 2025 American Society of ...

Cizzle Bio, Inc. announced today the online publication of a new study abstract in conjunction with the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, projecting that its ...

Tempus AI, Inc.'s unique data assets and AI-driven oncology solutions make it a promising buy. Click to read more on why the ...